What Percentage of Patients With Newly Diagnosed Carcinoma of the Prostate are Candidates for Surveillance? An Analysis of the CaPSURE™ Database

Journal of Urology

Volumn 180, Issue 4, 2008, Pages 1330-1335

  Barocas, Daniel A ^a   Cowan, Janet E ^b   Smith Jr , Joseph A ^a   Carroll, Peter R ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Urologic Outcomes Research Group   (United States)

Author keywords

disease management; prostatic neoplasms; risk assessment

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER REGISTRY; CANCER RISK; CAPSURE; COHORT ANALYSIS; DATA BASE; DEMOGRAPHY; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CHI-SQUARE DISTRIBUTION; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OBSERVATION; PATIENT SELECTION; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 51149102477     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.06.019     Document Type: Article

References (20)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43
2. Epstein J.I., Walsh P.C., Carmichael M., and Brendler C.B. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271 (1994) 368
3. Carter H.B., Sauvageot J., Walsh P.C., and Epstein J.I. Prospective evaluation of men with stage T1C adenocarcinoma of the prostate. J Urol 157 (1997) 2206
4. Klotz L. Active surveillance for prostate cancer: for whom?. J Clin Oncol 23 (2005) 8165
5. Carter H.B., Walsh P.C., Landis P., and Epstein J.I. Expectant management of nonpalpable prostate cancer with curative intent: preliminary results. J Urol 167 (2002) 1231
6. Lubeck D.P., Litwin M.S., Henning J.M., Stier D.M., Mazonson P., Fisk R., et al. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 48 (1996) 773
7. D'Amico A.V., Whittington R., Malkowicz S.B., Schultz D., Blank K., Broderick G.A., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969
8. Greene K.L., Cowan J.E., Cooperberg M.R., Meng M.V., DuChane J., and Carroll P.R. Who is the average patient presenting with prostate cancer?. Urology 66 (2005) 76
9. Revelo M.P., Cookson M.S., Chang S.S., Shook M.F., Smith Jr. J.A., and Shappell S.B. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 171 (2004) 646
10. Moutzouris G., Barbatis C., Plastiras D., Mertziotis N., Katsifotis C., Presvelos V., et al. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder. Scand J Urol Nephrol 33 (1999) 27
11. Abbas F., Hochberg D., Civantos F., and Soloway M. Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer. Eur Urol 30 (1996) 322
12. Sakr W.A., Grignon D.J., Crissman J.D., Heilbrun L.K., Cassin B.J., Pontes J.J., et al. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo 8 (1994) 439
13. Guileyardo J.M., Johnson W.D., Welsh R.A., Akazaki K., and Correa P. Prevalence of latent prostate carcinoma in two U.S. populations. J Natl Cancer Inst 65 (1980) 311
14. Bill-Axelson A., Holmberg L., Ruutu M., Haggman M., Andersson S.O., Bratell S., et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352 (2005) 1977
15. Albertsen P.C., Hanley J.A., and Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293 (2005) 2095
16. Warlick C., Trock B.J., Landis P., Epstein J.I., and Carter H.B. Delayed versus immediate surgical intervention and prostate cancer outcome. J Natl Cancer Inst 98 (2006) 355
17. Roemeling S., Roobol M.J., Postma R., Gosselaar C., van derKwast T.H., Bangma C.H., et al. Management and survival of screen-detected prostate cancer patients who might have been suitable for active surveillance. Eur Urol 50 (2006) 475
18. Miller D.C., Gruber S.B., Hollenbeck B.K., Montie J.E., and Wei J.T. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. J Natl Cancer Inst 98 (2006) 1134
19. Cooperberg M.R., Lubeck D.P., Meng M.V., Mehta S.S., and Carroll P.R. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 22 (2004) 2141
20. Harlan L.C., Potosky A., Gilliland F.D., Hoffman R., Albertsen P.C., Hamilton A.S., et al. Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst 93 (2001) 1864